Cargando…

Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data

PURPOSE: To investigate real-world prescribing trends and clinical outcomes based on body mass index (BMI) categorization in patients who received rivaroxaban therapy. METHODS: This was a retrospective cohort study involving all patients who received rivaroxaban therapy across all Hamad Medical Corp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alalawneh, Majdoleen, Rachid, Ousama, Abdallah, Ibtihal, Mahfouz, Ahmed, Elewa, Hazem, Danjuma, Mohammed Ibn-Mas‘ud, Mohamed, Asmaa Ezzeldin, Awaisu, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663176/ https://www.ncbi.nlm.nih.gov/pubmed/37816816 http://dx.doi.org/10.1007/s00228-023-03572-7

Ejemplares similares

Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
por: Alalawneh, Majdoleen, et al.
Publicado: (2022)

Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country
por: Zaghloul, Nancy, et al.
Publicado: (2022)

Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020
por: Abdelkader, Nada Nabil, et al.
Publicado: (2023)

Pharmacogenomics In Pharmacy Practice: Current Perspectives
por: Elewa, Hazem, et al.
Publicado: (2019)

Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2019)

Median arcuate ligament syndrome masquerading as mesenteric angina
por: Chapra, Ammar, et al.
Publicado: (2021)

What is polypharmacy in people living with HIV/AIDS? A systematic review
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2022)

Improving Syrian refugees’ knowledge of medications and adherence following a randomized control trial assessing the effect of a medication management review service
por: Alalawneh, Majdoleen, et al.
Publicado: (2022)

An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Rivaroxaban prescribing in a Saudi tertiary care teaching hospital
por: Mayet, Ahmed Yacoob, et al.
Publicado: (2018)

Critical care tele‐pharmacy services during COVID‐19 pandemic: A qualitative exploration of healthcare practitioners' perceptions
por: Isleem, Nour, et al.
Publicado: (2022)

Prevalence and global trends of polypharmacy in patients with chronic liver disease: A systematic review and meta-analysis
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2023)

Treatment Failure of Cerebral Venous Thrombosis With Rivaroxaban: A Case Report and Narrative Review
por: Mohamed, Mustafa, et al.
Publicado: (2022)

The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations
por: Ashton, Veronica, et al.
Publicado: (2020)

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2021)

Efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type II diabetes: A protocol for systematic review of randomised controlled clinical trials utilising a generalised pairwise modelling methodology
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2019)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Speed, Victoria, et al.
Publicado: (2021)

Appropriateness of Prescribing Rivaroxaban at King Khalid University Hospital Riyadh
por: Arishi, Ghazi I, et al.
Publicado: (2022)

Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial
por: Al-Sulaiti, Fatima Khalifa, et al.
Publicado: (2019)

Perspectives of future pharmacists on the potential for development and implementation of pharmacist prescribing in Qatar
por: Diab, Mohammad Issam, et al.
Publicado: (2020)

Weight Gain, Obesity, and Psychotropic Prescribing
por: Nihalani, Nikhil, et al.
Publicado: (2011)

Ecofriendly densitometric RP-HPTLC method for determination of rivaroxaban in nanoparticle formulations using green solvents
por: Alam, Prawez, et al.
Publicado: (2020)

An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS)
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing
por: Kampouraki, Emmanouela, et al.
Publicado: (2020)

Evaluating prescribing competencies covered in a Canadian-accredited undergraduate pharmacy program in Qatar: a curriculum mapping process
por: Abdallah, Oraib, et al.
Publicado: (2020)

National assessment of pharmaceutical workforce and education using the International Pharmaceutical Federation’s global development goals: a case study of Qatar
por: Mukhalalati, Banan Abdulrzaq, et al.
Publicado: (2021)

Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
por: Alberts, Mark J., et al.
Publicado: (2022)

Rivaroxaban Monotherapy for Atrial Fibrillation and Coronary Artery Disease in Underweight/Obese Patients: Evidence Is Needed
por: Zhou, Dao, et al.
Publicado: (2022)

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
por: Eljilany, Islam, et al.
Publicado: (2021)

Exploring the Role of Community Pharmacists in Obesity and Weight Management in Qatar: A Mixed-Methods Study
por: AlMukdad, Sawsan, et al.
Publicado: (2021)

The role of rivaroxaban in left ventricular thrombi
por: Abdelnaby, Mahmoud, et al.
Publicado: (2019)

Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology
por: Danjuma, Mohammed ibn-Mas’ud, et al.
Publicado: (2020)

Comparison of biotechnological culture of hypoxia-conditioned rat mesenchymal stem cells with conventional in vitroculture of normoxia-conditioned rat mesenchymal stem cells for testicular failure therapy with low libido in rats
por: Safitri, Erma, et al.
Publicado: (2019)

Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report
por: Fahmi, Amr Mohamed, et al.
Publicado: (2016)

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
por: Weir, Matthew R., et al.
Publicado: (2021)

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
por: Salem, Muhammad, et al.
Publicado: (2021)

Strategic public procurement regulatory compliance model with mediating effect of ethical behavior
por: Sarawa, Dauda Ibrahim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0rg06j7a2oci7r99l74cmptrq3